Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 412

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning

Open access
Riley, James L., June, Carl H., Blazar, Bruce R.·2009·Immunity

Abstract

Summary Immune system regulation is of paramount importance to host survival. In settings of autoimmunity and alloimmunity, control is lost, resulting in injury to vital organs and tissues. Naturally occurring, thymic-derived T regulatory cells (Tregs) that express CD4, CD25 and the forkhead box protein 3 (FoxP3) are potent suppressors of these adverse immune responses. Preclinical studies have shown that either freshly isolated or ex vivo expanded Tregs can prevent both local and systemic organ and tissue destruction. Although promising, human Treg infusion therapy has heretofore been difficult to implement in the clinic, and relatively few clinical trials have been initiated. This review will focus on the preclinical models that provide the rationale for current trials and it will address both the challenges and opportunities in human Treg therapy.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.immuni.2009.04.006

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Cited by

See all 412

Metadata

Authors
Riley, J. L., June, C. H., & Blazar, B. R.
Venue
Immunity
Publisher
Elsevier BV
Published
2009-05
Volume
30
Issue
5
Pages
656-665
ISSN
1074-7613 (ISSN-L)
OpenAlex
W2160700813
Cited by
412
References
11
FWCI
22.53
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning. https://app.cochat.ai/papers/10.1016/j.immuni.2009.04.006
The paper
Riley, J. L., June, C. H., & Blazar, B. R. (2009). Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning. Immunity. https://doi.org/10.1016/j.immuni.2009.04.006

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.